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Recent studies indicate that chromatin regulatory complexes produce biological specificity in 
the way that letters produce meanings by combinations into words. Combinatorial assembly of 
chromatin regulatory complexes may be critical for maximizing the information content provided 
by arrays of histone modifications.The DNA within each mammalian cell is 
compacted about 5000-fold into chro-
matin with hierarchical levels of com-
plexity, the simplest being a nucleosome 
with about 7-fold compaction. This com-
paction is controlled by at least three 
mechanisms: DNA methylation, histone 
modifications, and the ATP-dependent 
chromatin remodeling complexes. The 
latter contain SWI2/SNF2-like ATPases 
and regulate the presence and posi-
tion of nucleosomes on DNA, enabling 
the binding of transcription factors to 
nucleosomes and the facilitation of DNA 
recombination, repair, and viral integra-
tion (Cairns, 2007).
The vertebrate genome contains ~30 
genes encoding proteins similar to the 
yeast SWI2/SNF2 ATPases, which are 
essential for mating type switching and 
nutrient responses in yeast (Neigeborn 
and Carlson, 1984; Stern et al., 1984). 
The diversity of this ATPase family in 
vertebrates suggests that the function 
of this class of proteins is both broader 
and yet more specific than anticipated. 
Compounding this potential diversity is 
the observation that these ATPases are 
generally present in complexes with 4 to 
12 other protein subunits. In vertebrates, 
these subunits are often encoded by 
gene families, indicating that the diver-
sity of these complexes might be further 
enhanced by combinatorial assembly. 
Characterized complexes include those 
containing the SNF2L, SNF2H, Mi-2α, 
Mi-2β, Brg, and Brm ATPases (Figure 1).
The mSWI/SNF or BAF complexes of 
vertebrates illustrate the features of com-
binatorial assembly and prompt an anal-
ogy: the subunits of these complexes 200 Cell 136, January 23, 2009 ©2009 Elsevare like letters and can be assembled in 
different combinations to form new com-
plexes (words). Although initially thought 
to be analogous to yeast SWI/SNF com-
plexes, recent genome-wide studies 
have found that vertebrate mSWI/SNF or 
BAF complexes most commonly repress 
their target genes, whereas the yeast 
SWI/SNF complex has only been found 
to activate its targets. These mechanistic 
differences likely derive from differences 
in subunit composition (Lessard et al., 
2007: Cairns, 2007; Zhao et al., 1998) 
(Table S1 and Figure S1 available online). 
The subunits appear to have been shuf-
fled between complexes, with some sub-
units lost and new ones incorporated, at 
the evolutionary origin of multicellular 
organisms. This remodeling may have 
occurred in response to the appear-
ance of linking histones and the need for 
extensive cell type specialization.
Biochemical studies have defined 
certain rules for combinatorial assem-
bly of the vertebrate mSWI/SNF or BAF 
family of complexes. First, 20 genes 
encode the 11 subunits of these com-
plexes (Table 1) giving a total of 288 
predicted assemblies. Second, studies 
using antibodies specific for the prod-
ucts of genes encoding different sub-
unit family members revealed that these 
subunits are freely combined with other 
subunits in cultured cells (Wang et al., 
1996; Zhao et al., 1998). Third, the 11 
subunits resist dissociation even under 
near-denaturing conditions. Importantly, 
challenge with in vitro synthesized sub-
units indicated that these subunits are 
not exchangeable (Zhao et al., 1998), 
suggesting that the complexes may ier Inc.form stable, conformationally specific 
assemblies, which would be critical for 
diversifying their functions. Thus, BAF 
complexes can be viewed as an 11-let-
ter chromatin remodeling word with 288 
possible spellings (Figure 1). During 
evolution, expansion of the gene fami-
lies encoding the different subunits first 
appeared in the genomes of organisms 
that shared a common ancestor about 
500 million years ago, the dawn of verte-
brate life (Figure S1). Thus, combinato-
rial assembly of these complexes, along 
with combinatorial use of transcription 
factors (Levine and Tjian, 2003), may 
have contributed to the diversification of 
gene function in vertebrates by endow-
ing a common set of genes with differ-
ent expression patterns.
Chromatin Remodeling Words: 
Misspelling and Respelling
An appropriate test of the analogy to 
the assembly of words is to examine 
the biological consequences of different 
“spellings” or “misspellings” (i.e., substi-
tution of one letter or subunit for another 
by genetic or biochemical manipulation) 
that might create new meanings. Verte-
brate SWI/SNF complexes contain two 
alternative ATPases, Brg or Brm, but not 
both (Figure 1). A growth suppressor or 
tumor suppressor role for Brg and Brm 
was first proposed from studies of cell 
lines that lack both the Brg and Brm sub-
units (Dunaief et al., 1994). Introduction 
of Brg slowed growth of the cell lines and 
induced differentiation, whereas Brm 
had little effect. Brg mutant mice die on 
embryonic day 3 due to growth arrest of 
the inner cell mass and trophoblast (Bult-
Figure 1. Combinatorial Assembly of Chromatin Regulatory Complexes
Shown is the predicted combinatorial diversity for the mammalian chromatin regulatory complexes: BAF (mSWI/SNF), NuRD, ISWI, and Polycomb (the number 
of possible combinations is shown in parentheses in red). 
(Top) Three examples of BAF complexes illustrate respelling of the chromatin remodeling word by switching subunit composition. The subunits are depicted as 
interlocking pieces in which a similar shape of the subunit denotes homology and thereby a specific position in the complex. Subunits shown in dashed outline 
are inconstant components of the complexes. The positions of the proteins in the complexes are arbitrary 2D projections, except for actin and BAF53,which 
contact the catalytic domain of Brg (Zhao et al., 1998). The depicted area of each subunit is roughly proportional to its mass.man et al., 2000), whereas Brm-deficient 
mice are slightly larger than normal but 
otherwise viable (Reyes et al., 1998). Brg 
is one of the few known genes required 
for zygotic gene activation, a process 
that is not affected by the absence of 
Brm (Bultman et al., 2006). In addi-
tion, Brg but not Brm plays an essential 
and specific role in the self-renewal of 
embryonic stem (ES) cells (Bultman et 
al., 2000) and neural stem cells (Lessard 
et al., 2007), lymphocyte development 
(Chi et al., 2002), and limb morphogen-
esis (Indra et al., 2005). These genetic 
studies suggested that the functions of 
these two ATPases in BAF complexes 
are different but left open the possibility 
that this was simply due to patterns of 
expression.In vitro biochemical studies also sug-
gested that the Brg- and Brm-based 
ATPases have different activities. Brg and 
Brm preferentially interact with different 
classes of transcription factors through 
their unique N-terminal domains (Kadam 
and Emerson, 2003). Brg binds to zinc fin-
ger proteins such as KLF and GATA fam-
ily transcription regulators, whereas Brm 
interacts with two ankyrin repeat proteins 
involved in Notch signaling (however, Brm 
mutants have no defect in Notch signal-
ing). Thus, these studies also implicate 
distinct roles for complexes containing 
Brg and Brm. However, a rigorous test of 
the biological specificity of the ATPase 
subunit by expressing Brg or Brm in a 
mouse with the opposite mutant back-
ground has not been reported.Cell 136The 60 kDa (BAF60 family) subunit is 
encoded by three genes, but only one 
subunit type is present per complex 
(Figure 1) (Wang et al., 1996). BAF60c is 
expressed selectively in the embryonic 
heart, and downregulation of BAF60c 
by RNA interference in the early mouse 
embryo resulted in defective heart 
development and death at embryonic 
days 10–11 (Lickert et al., 2004). Trans-
genic expression of the BAF60b protein 
repressed the heart defect suggest-
ing that “misspelling” of the chromatin 
remodeling word did not change the 
original biological meaning. However, 
the small amount of tissue available and 
lack of subunit-specific antibodies made 
it impossible to examine the degree of 
expression of the protein in the proper , January 23, 2009 ©2009 Elsevier Inc. 201




Brg, Brm ATPase, Bromodomain, HSA, BRK
BAF170 Chromo-related domain, SWIRM, SANT, Leu-zipper
BAF155 Chromo-related domain, SWIRM, SANT, Leu-zipper
BAF57 HMG, coiled-coil
BAF47/SNF5/Ini SNF5 domain
BAF60a, b, c SWIB/MDM2 domain
β-actin actin
BAF45d PHD, Krüppel, N-terminal
npBAF-specific BAF53a actin-related protein
npBAF-specific BAF45a,d PHD, Krüppel
nBAF-specific BAF53b actin-related protein
nBAF-specific BAF45b, c PHD, Krüppel, N-terminal
BAF-specific BAF250a, b ARID
PBAF-specific BAF200/ARID2 ARID, RFX, Zn finger
PBAF-specific BAF180 Bromodomain (6), BAH, HMG
NuRD/Mi-2 Mi-2α, β  ATPase, Chromodomain, PHD
MTA1, 2, 3 BAH, ELM, SANT, Zn finger
HDAC1, HDAC2 HDAC domain
RbAP46, 48 WD40
MBD2, MBD3 MBD
P66a, p66b Zn finger
ISWI NURF SNF2L ATPase, HAND, SANT, SLIDE
BPTF PHD, Bromodomain, HMG, WAC, WAKZ
RbAP46/48 WD40 
ACF/WCRF SNF2H ATPase, HAND, SANT, SLIDE
ACF1/WCRF180 PHD, Bromodomain, WAC, LH, BAZ1, BAZ2, WAKZ
CHRAC SNF2H ATPase, HAND, SANT, SLIDE
ACF1/WCRF180 PHD, Bromodomain, WAC, LH, BAZ1, BAZ2, WAKZ
CHRAC-15, 17 Histone-fold domain
WICH SNF2H ATPase, HAND, SANT, SLIDE
WSTF PHD, Bromodomain, WAC, LH, BAZ1, BAZ2, WAKZ
RSF SNF2H ATPase, HAND, SANT, SLIDE
RSF-1/p325 PHD
NoRC SNF2H ATPase, HAND, SANT, SLIDE
TIP5 PHD, Bromodomain, MBD, HMG, LH, BAZ1, BAZ2, 
WAKZ
SNF2H/cohesin SNF2H ATPase, HAND, SANT, SLIDE
NuRD (Mi-2, HDAC1/2, MBD2/3, MTA1/2, 
RbAp46/48)
Cohesin (hRAD21, hSMC1/2, SA1/SA2)
PRC1 CBX2/HPC1, CBX4/HPC2, CBX6, CBX7, CBX8/
HPC3
Chromodomain, AT-hook
PHC1, 2, 3 FCS Zn finger, SAM domain
RING1A, RING1B RING finger
Bmi1, Mel18, MBLR, NSPc1 RING finger
PRC2 EZH1, EZH2 SET, SANT
EED WD40
SUZ12 Zn finger
Domains with the ability to interact with histones are shown in bold.202 Cell 136, January 23, 2009 ©2009 Elsevier Inc.
site or its incorporation into complexes, 
leaving the authors to speculate that the 
functions of the BAF60b and BAF60c 
subunits are interchangeable.
A good example of how nature 
respells chromatin remodeling words is 
provided by the PBAF complex (Figure 
1). Using a nuclear receptor-dependent 
in vitro transcription assay, Tjian and 
colleagues purified chromatin remodel-
ing cofactors from cultured cells that 
supported transcription in response 
to ligand-activated nuclear receptors. 
Remarkably, the responsible complex 
contained Brg selectively paired with 
BAF180/Polybromo (Lemon et al., 2001). 
In these PBAF complexes, BAF200 
(ARID2) replaces BAF250a (ARID1a) and 
BAF250b (ARID1b), which also contain 
ARID domains (Figures 1 and S1) (Yan 
et al., 2005). PBAF complexes activated 
vitamin D receptor-dependent transcrip-
tion in response to vitamin D, whereas 
BAF complexes containing BAF250 
but not BAF200 or BAF180 failed to do 
so (Lemon et al., 2001). BAF180 con-
tains six Bromodomains that bind to 
acetylated histone, and so this subunit 
could help to target the complex. Mice 
lacking BAF180 have defects in heart 
development that are consistent with a 
role in responses to retinoic acid (Wang 
et al., 2004b), but earlier retinoic acid-
dependent processes do not appear to 
be affected. Most BAF180 in nontrans-
formed cells resides in larger complexes 
lacking Brg (Lessard et al., 2007), mak-
ing interpretation of the genetic data 
less clear. The combinatorial composi-
tions of the complexes in the affected 
heart field remain undefined. PBAP, the 
Drosophila homolog of PBAF, shares 
most subunits with BAF complexes but 
also contains Polybromo, BAP170 (an 
ARID2 homolog), and a protein similar 
to BAF45a (SAYP) (Figure S1) (Chalkley 
et al., 2008). Although flies lacking either 
Polybromo or BAP170 are viable, double 
mutant flies lacking both PBAP subunits 
have defects in metamorphosis and 
fail to activate genes involved in innate 
immunity but surprisingly have normal 
responses to the insect nuclear hormone 
ecdysone (Carrera et al., 2008). As this 
phenotype is distinct from those caused 
by mutations in BAP complex subunits, 
it is likely that the PBAP combination of 
subunits has a distinct function.Recent studies suggest that combi-
natorial assembly may underlie differ-
ent aspects of pluripotency. Mutation of 
three subunits of BAF complexes—Brg, 
BAF155, and BAF47—severely compro-
mises the survival of the inner cell mass 
of the mammalian embryo (Bultman et al., 
2000; Guidi et al., 2001; Kim et al., 2001; 
Klochendler-Yeivin et al., 2000), suggest-
ing an essential role of BAF complexes in 
the self-renewal and differentiation of pluri-
potent ES cells. This phenotype appears 
specific to pluripotent cells, as Brg is not 
essential for proliferation of fibroblasts or 
glia but is essential for the multipotency 
of neural stem cells (Bultman et al., 2000; 
Lessard et al., 2007). Remarkably, mouse 
embryos lacking BAF250a (ARID1a) form 
the inner cell mass but do not gastrulate 
or form mesoderm. ES cells derived from 
these embryos have severely compro-
mised pluripotency and defective self-
renewal (Gao et al., 2008). In contrast, ES 
cells lacking BAF250b show a mild reduc-
tion in proliferation, decreased expression 
of pluripotency genes, and more rapid 
differentiation (Yan et al., 2008). Thus, 
different aspects of ES cell function may 
require complexes with a different “letter” 
at the BAF250 position, although rescue 
of null mutations with the homologous 
proteins will be necessary to justify this 
conclusion.
In studies of growth regulatory chro-
matin remodeling complexes, it is often 
forgotten that mutation of complex com-
ponents may result in a growth advan-
tage leading to the predominance of 
clones lacking one or more subunits of a 
specific complex. For example, multiple 
human tumor cell lines such as SW13 
cells lack Brg and/or Brm (Dunaief et al., 
1994; Wong et al., 2000), malignant rhab-
doid tumors lack BAF47 (Versteege et al., 
1998), and other cell lines lack BAF57 and 
BAF155. HeLa tumor cells lack the BAF45 
family and have only about 30,000 com-
plexes per cell, whereas nontransformed 
cells have about 10 times this number 
(Lemon et al., 2001; Lessard et al., 2007). 
Thus, the study of nontransformed cells is 
essential to understanding the biochemi-
cal and functional diversity of this family 
of chromatin remodeling complexes.
Studies of BAF complexes in the 
developing nervous system have defined 
an essential switch in subunits at mitotic 
exit that constitutes a natural respell-Cell 136ing of the chromatin remodeling word. 
Mitotic exit in the nervous system marks 
the end of multipotency. The transition 
from neural stem cells to neurons occurs 
with anatomical precision in the embryo 
making this a convenient system to study 
the switch between multipotency and 
committed fate. The first purification and 
proteomic analysis of complexes from 
nontransformed vertebrate cells showed 
that multipotent neural stem cells and 
progenitors have complexes containing 
BAF53a and BAF45a but not BAF60b 
(npBAF in Figure 1). Complexes in post-
mitotic neurons (nBAF) have BAF53b, 
BAF45b but not BAF60b (Lessard et al., 
2007; Wu et al., 2007). Both complexes 
appear to be polymorphic at positions 
occupied by other subunits. Subunit 
exchange occurs at mitotic exit probably 
within one cell division, and the com-
plexes of progenitor cells and neurons 
appear to be mutually exclusive indicat-
ing that respelling is precise (Lessard et 
al., 2007). These findings set the stage 
for a definitive test of whether different 
complexes have different functions.
The npBAF complexes appear to be 
both necessary and sufficient for neu-
ral stem cell self-renewal (Lessard et 
al., 2007), whereas nBAF complexes 
are essential for dendritic and axonal 
morphogenesis (Wu et al., 2007). These 
studies suggest that these two families 
of complexes function differently, but 
could the functional specificity be due 
to their different expression patterns? 
A more rigorous test was provided by 
mice lacking BAF53b, a dedicated sub-
unit of postmitotic neuron-specific nBAF 
complexes (Wu et al., 2007). BAF53b is 
exclusively expressed in neurons, and 
null mice die perinatally with a failure 
to nurse, reduced neurite outgrowth, 
and reduced synapse formation. The 
latter defect is probably due to the fact 
that nBAF complexes directly bind and 
regulate cytoskeleton genes necessary 
for dendritic morphogenesis. The lethal 
defects in BAF53b null mice were res-
cued by BAF53b but not by BAF53a (Wu 
et al., 2007). These studies demonstrate 
that complexes containing BAF53a and 
BAF53b have distinct functions that are 
not simply a product of their pattern of 
expression. Thus, combinatorial assem-
bly, at least at this position in BAF com-
plexes, produces functional diversity., January 23, 2009 ©2009 Elsevier Inc. 203
Words of Other Chromatin 
 Regulatory Complexes
The gene families encoding the subunits 
of other chromatin remodeling and mod-
ifying complexes suggest that combina-
torial assembly might also dictate speci-
ficity in these complexes (Table 1; Figure 
1). The NuRD/Mi-2 complexes can be 
viewed as a chromatin remodeling word 
with six letters containing both a SNF2-
like ATPase and a histone deacetylase 
(Xue et al., 1998). All six subunits are 
encoded by gene families in vertebrates 
giving 48 possible complexes (Bowen et 
al., 2004). Although genetic experiments 
in which a null mutation in one family 
member is substituted with another (mis-
spelling) have not been reported, sub-
stantial biochemical evidence indicates 
that at least some of the complexes have 
different functions.
The ISWI family of chromatin remodel-
ers appear to be two- to four-letter chro-
matin remodeling words based on the 
alternative ATPases, SNF2L and SNF2H 
(Figure 1), the mammalian homologs of 
the Drosophila ISWI ATPase (Eberharter 
and Becker, 2004). Not only do they dif-
fer in their expression pattern, but they 
assemble into at least seven distinct 
complexes. SNF2L is a component of the 
NURF complex, interacting with BPTF 
and RbpAp46/48 (Figure 1; Table 1). BPTF 
contains two PHD domains, which likely 
bring the chromatin remodeling activity 
of these complexes to genetic loci with 
specific histone modifications (Wysocka 
et al., 2006). The closely related protein, 
SNF2H, is found in at least six complexes 
(hACF, hCHRAC, hWICH, RSF, NoRC, 
and SNF2H/cohesin; Figure 1; Table 1) 
(Eberharter and Becker, 2004). Interest-
ingly, three protein partners of SNF2H 
in these complexes belong to the BAZ/
WAL family (ACF1 in hACF and hCHRAC, 
WSTF in WICH, TIP5 in NoRC) (Jones et 
al., 2000). In addition, the NURF com-
ponent BPTF also shares WAC, WAKZ, 
PHD, and Bromodomains with these 
BAZ/WAL family proteins. Thus, combi-
natorial assembly of SNF2L/2H proteins 
with a family of homologous subunits 
appears to diversify ISWI complexes 
structurally (Eberharter et al., 2001; Ham-
iche et al., 1999; Ito et al., 1999; Langst 
et al., 1999). Genetic and biochemical 
analyses indicate that ISWI complexes 
play important roles in transcriptional 204 Cell 136, January 23, 2009 ©2009 Elsevregulation, heterochromatin replica-
tion, chromatin assembly, and chroma-
tin higher-order structure. For example, 
TIP5 in the NoRC complex localizes in 
the nucleolus and mediates transcrip-
tional silencing of ribosomal RNA (rRNA) 
(Strohner et al., 2001). WSTF, but not the 
closely related ACF1, associates with 
mitotic chromosomes and maintains 
chromatin structures during DNA rep-
lication (Bozhenok et al., 2002; Poot et 
al., 2004). In contrast, ACF1 containing 
complexes function in chromatin for-
mation and assembly (Eberharter et al., 
2001; Fyodorov et al., 2004).
Polycomb Group (PcG) complexes 
modify histones and are key players in 
development (Schuettengruber et al., 
2007). Two types of PcG complexes 
(PRC1 and PRC2) with different histone 
modification activities maintain devel-
opmental regulatory genes in a silenced 
state. Vertebrate PRC1-like complexes 
can be considered as four-letter words 
with at least 60 predicted combinations 
(Whitcomb et al., 2007). The four core 
subunits (PHC, CBX, Bmi1, and RING1) 
(Table 1) are homologs of Drosophila Ph, 
Pc, Psc, and dRing, respectively (Figure 
1). For example, in mammals, there are 
at least four paralogs of the Drosophila 
RING finger protein Psc—Bmi1, Mel18, 
MBLR, and NSPc1—that interact with 
other PcG proteins to form a set of dis-
tinct but related complexes. For exam-
ple, NSPc1 together with Ring1B and 
other PRC1 subunits is a component of a 
BCOR corepressor complex (Gearhart et 
al., 2006), whereas MBLR together with 
Ring1B is implicated in the E2F6 com-
plex (Ogawa et al., 2002).
Genetic studies suggest that the 
mammalian orthologs of Psc may have 
overlapping and distinct functions. For 
example, Bmi1 and Mel18 share 63% 
amino acid identity, but only Bmi1 is 
required for maintaining hematopoietic 
and neural stem cells postnatally (Les-
sard and Sauvageau, 2003; Molofsky et 
al., 2003). Disruption of Bmi1 or Mel18 in 
mice results in posterior transformation 
of the axial skeleton, but their homeotic 
phenotypes are clearly distinct (Akasaka 
et al., 1996; van der Lugt et al., 1994). 
The nonoverlapping functions of Mel18 
and Bmi1 may reflect the fact that they 
participate in distinct PcG complexes 
(Elderkin et al., 2007).ier Inc.How many functions do PRC1 fam-
ily members have and do specific 
complexes carry them out? One of the 
functions of PRC1-like complexes is to 
monoubiquitinate chromatin on histone 
H2A at lysine residue 119. Although there 
are four Ring finger domains in PRC1, 
only the Ring fingers of the Ring1B and 
Ring1A subunits perform this function 
(Buchwald et al., 2006; Wang et al., 
2004a). Biochemical data also suggest 
that the Chromodomain-containing CBX 
family proteins (homologs of Drosophila 
Pc) bind differentially to trimethylated 
H3K27 and H3K9 and may target PRC1 
complexes to different loci (Bernstein et 
al., 2006). But whether histone ubiquit-
ination follows differential targeting of 
PRC1-like complexes to distinct loci by 
different Pc or Psc paralogs remains to 
be shown.
PRC2 complexes contain EED, SUZ12, 
and either EZH1 or EZH2. Hence, they 
can be viewed as three-letter words with 
only two possible combinations. The 
catalytic subunit EZH2 places the dim-
ethyl and trimethyl mark on H3K27 and is 
thought to be required for PRC1 action. 
Recent studies suggest that EZH1- and 
EZH2-based complexes have distinct 
and overlapping functions (Shen et al., 
2008). Although EED is encoded by one 
gene, four proteins are produced by alter-
native translational starts possibly adding 
to the diversity. (Alternative splice forms 
have not been included in the calculations 
of diversity in Figure 1, but they could 
contribute to diversity as indicated with 
different translated EED gene products.) 
These complexes appear to have differ-
ent in vitro specificity toward H3K27 and 
H1K26 (Kuzmichev et al., 2004). Although 
both EED and EZH2 are essential for di- 
and trimethylation of H3K27 in ES cells, 
they are surprisingly not required to gen-
erate pluripotent ES cells or for their self-
renewal (Shen et al., 2008). The lack of an 
effect of EZH2 mutation on pluripotency 
is not due to compensation by EZH1 
because removal of EED, which produces 
an even more severe defect in H3K27 
methylation, does not compromise pluri-
potency but does produce severe defects 
in later stages of embryonic development 
(Chamberlain et al., 2008). Hence, con-
ditional alleles will be essential to under-
standing the unique contributions of 
EZH1- and EZH2-based complexes.
Chromatin Remodeling Words and 
Histone Codes
Most of these findings support the con-
tention that combinatorial assembly of 
chromatin regulatory complexes under-
lies at least part of their biological speci-
ficity. The distinct complexes are not 
distinguished purely by a single subunit 
but rather by a combination of subunits, 
some of which, like BAF45b and BAF53b, 
occur together. Thus, similar to words 
such as “quiescence” and “queasiness,” 
different meanings are produced by 
combinations, yet some combinations, 
like “qu,” seem invariant. How might 
specificity arise at a molecular level?
The current model for the function of 
ATP-dependent remodeling complexes 
is that a core ATPase is necessary for 
the mobility of nucleosomes (Narlikar et 
al., 2002) and the other subunits interact 
with transcription factors that recruit the 
complexes to their sites of action. Thus, 
one possibility is that the different com-
posite surfaces produced by the differ-
ent combinations of subunits contact 
specific transcription factors (Figure 
2A). This mechanism may apply to PBAF 
complexes and their interaction with 
nuclear receptors (Lemon et al., 2001). 
The composite surfaces produced by 
the combination of BAF180, ARID2, and 
Brg with other subunits might provide 
a docking site for specific transcription 
factors (nuclear receptors in this case).
A more complex mechanism is sug-
gested by recent studies showing that 
BAF complexes might be polymorphic 
readers of histone modifications. These 
complexes contain two PHD domains in 
BAF45 (Lessard et al., 2007), seven acety-
lated histone-binding Bromodomains (six 
on BAF180 and one on Brg/Brm), and two 
Chromo-related domains (one in BAF155 
and one in BAF170), which might bind to 
methylated histones (Brehm et al., 2004). 
In addition, the complexes contain seven 
DNA-binding domains with relatively little 
sequence specificity (at least individually). 
Thus, different combinations of subunits 
within an essentially nonexchangeable 
complex could produce conformationally 
specific combinations allowing recogni-
tion of complementary arrays of modified 
histones (Figure 2B). The need to generate 
specific three-dimensional arrays of target-
ing moieties might explain why chromatin 
remodeling activities are nearly always part Figure 2. Biological Specificity by Combinatorial Assembly
Alternative, but not mutually exclusive, models for generating biological specificity by combinato-
rial assembly of ATP-dependent chromatin remodeling complexes. (A) Composite surface model in 
which transcription factors (TF) bind at interfaces of the subunits. (B) Conformational model in which 
the arrangement of histone modification recognition domains and DNA-binding domains within the 
complex leads to recognition of specific loci. Brg, BAF155, BAF170, BAF45, and BAF57 have either 
DNA-binding domains or domains that bind to modified histones and hence could target the complex 
to specific developmental loci independent of, or in cooperation with, transcription factors. (Not all of 
the domains are shown, but an exhaustive list appears in Table 1.) BAF-mediated looping of chroma-
tin (suggested by in vitro studies) illustrates the size of the BAF complex and its potential multivalent 
interactions with chromatin.of large multisubunit complexes. This line 
of reasoning also predicts different targets 
for npBAF and nBAF complexes, which 
contain different double PHD domain pro-
teins (BAF45a or BAF45b). Indeed, npBAF 
complexes containing the BAF45a subunit 
regulate about 400 target genes in neural 
stem cells with almost no overlap among 
the 200 target genes regulated by nBAF 
complexes containing BAF45b in neurons 
(Lessard et al., 2007; Wu et al., 2007).
The likely possibility that BAF com-
plexes are polymorphic readers of histone 
modifications predicts that combinatorial 
assembly of chromatin remodeling com-
plexes operates synergistically with the Cell 136proposed histone code to produce biolog-
ical specificity. Reading arrays of histone 
modifications with combinatorially gener-
ated assemblies of Bromodomains, Chro-
modomains, and PHD domains would 
allow highly specific targeting of chromatin 
regulators to matching three-dimension-
ally specific arrays of modified histones. 
The large size of BAF complexes (about 
12-fold bigger than a nucleosome) should 
enable reading of multiple histone modifi-
cations on adjacent nucleosomes (Figure 
2B). Biological specificity generated by 
this mechanism may be the product of the 
number of arrays of histone modifications 
on gene regulatory regions and the num-, January 23, 2009 ©2009 Elsevier Inc. 205
ber of conformationally specific arrays of 
recognition domains on the surface of the 
chromatin regulatory complexes. Future 
studies on the interdependence of the two 
mechanisms will be required to test this 
speculation. However, present evidence 
strongly supports a combinatorial strategy 
for generating and reading diverse chro-
matin landscapes.
Supplemental Data
Supplemental Data include one table and one figure 
and can be found with this article online at http://www.
cell.com/supplemental/S0092-8674(09)00015-4.
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